Clinical trial
Familial HNSCC Syndrome and p16 Germline Mutations
NCT00482872 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Familial HNSCC Syndrome and p16 Germline Mutations
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- July 31, 2012
- Enrollment
- 400 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer